Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
08 Jul 2021
Historique:
received: 20 04 2021
accepted: 03 06 2021
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 17 7 2021
Statut: epublish

Résumé

ERAP1 is a key aminopeptidase involved in peptide trimming before major histocompatibility complex (MHC) presentation. A single nucleotide polymorphism (SNP) in the ERAP1 gene can lead to impaired trimming activity and affect ERAP1 function. ERAP1 genetic variations have been linked to an increased susceptibility to cancer and autoimmune disease. Here, we report the discovery of novel ERAP1 inhibitors using a high throughput screening approach. Due to ERAP1 broad substrate specificity, the hit finding strategy included testing inhibitors with a range of biochemical assays. Based on the hit potency, selectivity, and

Identifiants

pubmed: 34267884
doi: 10.1021/acsmedchemlett.1c00235
pmc: PMC8274102
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1137-1142

Informations de copyright

© 2021 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Nat Immunol. 2002 Dec;3(12):1169-76
pubmed: 12436109
Hum Immunol. 2019 May;80(5):281-289
pubmed: 30419264
Nat Struct Mol Biol. 2011 May;18(5):604-13
pubmed: 21478864
Genes Immun. 2014 Dec;15(8):521-7
pubmed: 25142031
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19890-5
pubmed: 24248368
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17107-12
pubmed: 16286653
Mol Immunol. 2015 Oct;67(2 Pt B):426-35
pubmed: 26224046
J Med Chem. 2020 Jan 9;63(1):103-121
pubmed: 31841350
PLoS One. 2008;3(11):e3658
pubmed: 18987748
Mol Immunol. 2020 May;121:7-19
pubmed: 32135401
Nat Immunol. 2002 Dec;3(12):1177-84
pubmed: 12436110
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17594-9
pubmed: 25422414
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4122-6
pubmed: 27390066
J Biomol Screen. 2002 Dec;7(6):531-40
pubmed: 14599351
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
Anal Biochem. 2009 Dec 1;395(1):33-40
pubmed: 19638272
J Immunol. 2013 Jun 1;190(11):5839-46
pubmed: 23610143
Proc Natl Acad Sci U S A. 2019 Dec 16;:
pubmed: 31843903
J Immunol. 2011 Feb 15;186(4):1909-13
pubmed: 21242517

Auteurs

Safia Deddouche-Grass (S)

Sanofi, 67080 Strasbourg, France.

Cyrielle Andouche (C)

Sanofi, 67080 Strasbourg, France.

Felix Bärenz (F)

Sanofi, D-65926 Frankfurt am Main, Germany.

Célia Halter (C)

Domain Therapeutics, 67400 Illkirch, France.

Arnaud Hohwald (A)

Sanofi, 67080 Strasbourg, France.

Louison Lebrun (L)

Domain Therapeutics, 67400 Illkirch, France.

Nathalie Membré (N)

Sanofi, 67080 Strasbourg, France.

Renaud Morales (R)

Sanofi, 67080 Strasbourg, France.

Nicolas Muzet (N)

Sanofi, 67080 Strasbourg, France.

Matthieu Poirot (M)

Sanofi, 67080 Strasbourg, France.

Morgane Reynaud (M)

Biosynex, 67400 Illkirch, France.

Véronique Roujean (V)

Sanofi, 67080 Strasbourg, France.

Fabienne Weber (F)

Sanofi, 67080 Strasbourg, France.

André Zimmermann (A)

Sanofi, 67080 Strasbourg, France.

Rama Heng (R)

Evotec, 31036 Toulouse cedex, France.

Nicolas Basse (N)

Sanofi, 67080 Strasbourg, France.

Classifications MeSH